Trial
NCT02853500
Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
—
Condition
Liver Cancer
Intervention
TriNav
Why stopped
No participants enrolled. Inability to perform intraprocedural MRI with the intraarterial infusion catheter in place due to MRI incompatibility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-05